Liaoning Kelong Fine Chemical Inc
Liaoning Kelong Fine Chemical Inc is a specialty chemicals company that produces and sells fine chemicals, primarily used in the pharmaceutical and agricultural industries.
Business. Liaoning Kelong Fine Chemical Inc (300405.SZ) is a specialty chemicals company operating within the Basic Materials sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Liaoning Kelong Fine Chemical Inc (300405.SZ) is a specialty chemicals company operating within the Basic Materials sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Liaoning Kelong Fine Chemical Inc has a debt-to-equity ratio of 1.07, indicating a moderate reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio of 1.08, suggesting it has just enough current assets to cover its current liabilities. However, the company's free cash flow is negative at -49.94 million CNY, and its operating cash flow is only 31.15 million CNY, which may limit its ability to fund operations and debt obligations without external financing.
Profitability metrics show significant underperformance. The company reported a net loss of 49.83 million CNY and an operating loss of 64.78 million CNY. Return on equity is -11.13%, and return on assets is -4.74%, both well below the typical performance of companies in the specialty chemicals industry. These figures indicate that the company is not generating returns for shareholders or effectively utilizing its assets.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns and regulatory changes. The absence of segment or geographic breakdown in the financial data suggests a high concentration risk, which is not uncommon for smaller firms in the specialty chemicals industry.
Looking ahead, the company's growth trajectory is uncertain. The most recent financial data does not provide a clear outlook for the current or next fiscal year. The negative operating and net income, combined with a negative free cash flow, suggest that the company may need to seek additional financing or cost-cutting measures to sustain operations. The absence of a disclosed growth strategy or capital allocation plan further complicates the outlook.
Risk factors include liquidity constraints and the potential for dilution. The company has a low dilution risk, but its net cash position is negative after subtracting total debt, which could necessitate future equity or debt offerings. The company has not disclosed any recent dilutive events, and the dilution potential is currently assessed as low. However, the negative free cash flow and operating losses may pressure the company to raise capital in the near term.
Recent events include the publication of the latest financial results, which show a significant decline in profitability. The company has not disclosed any major strategic initiatives or new product launches in the most recent filings. The absence of recent positive developments or guidance from management raises concerns about the company's ability to reverse its current financial trajectory.
- The company is experiencing significant financial distress, with negative net and operating income.
- Liquidity is constrained, with a current ratio of 1.08 and negative free cash flow.
- Profitability metrics are well below industry norms, indicating poor performance.
- The company lacks geographic and segment diversification, increasing concentration risk.
- The outlook for the next fiscal year is uncertain, with no clear growth strategy or capital allocation plan.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Liaoning Kelong Fine Chemical Inc Market data — financials · 2026-05-26